Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

Dendritic cell (DC)-based cancer vaccines hold the great promise of tipping the balance from tolerance of the tumor to rejection. In the last two decades, we have gained tremendous knowledge about DC-based cancer vaccines. The maturation of DCs has proven indispensable to induce immunogenic T cell r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sittig, Simone P., de Vries, I. Jolanda M., Schreibelt, Gerty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344227/
https://www.ncbi.nlm.nih.gov/pubmed/28536413
http://dx.doi.org/10.3390/biomedicines3040282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344227/
https://www.ncbi.nlm.nih.gov/pubmed/28536413
http://dx.doi.org/10.3390/biomedicines3040282

Ejemplares similares